In the STEP 4 trial, participants who stopped semaglutide regained about two-thirds of the weight theyd lost within one year
The platform describes a structure that includes licensed medical providers making independent prescribing decisions, pharmacy partners the company states are LegitScript-certified, all-inclusive pricing, and ongoing medical support
Certain conditions, such as thyroid disorders or pancreatitis history, may require alternative approaches
Andreatta M, Karosiene E, Rasmussen M, Stryhn A, Buus S, Nielsen M
Clinical Trial Evolution and Results (20252026) As of early 2026, Retatrutide has reached critical milestones in Phase 3 clinical testing